SciClone Pharmaceuticals

SciClone Pharmaceuticals has been dedicated to the field of immunotherapy in China for over two decades, boasting an outstanding product portfolio, extensive market presence, and a strong brand reputation in oncology and hepatology within the Chinese market.

SciClone's flagship product, ZADAXIN (thymalfasin for injection), has been approved for marketing in multiple countries and regions across Europe, the Americas, and Asia. It has been a bestseller in China for over 20 years, consistently holding a leading market share among similar products, and has accumulated extensive clinical application experience, with its efficacy and quality recognized by experts and patients alike. Additionally, through collaborations with internationally renowned manufacturers, SciClone has introduced high-quality products that have gained excellent reputation in international markets into China. For example, DC Bead, a novel product for the treatment of liver cancer, has already been launched in China, and numerous other products are in late-stage development or undergoing regulatory approval. Furthermore, we have established partnerships with companies such as Baxter and Pfizer to promote a variety of branded products across different therapeutic areas in China, achieving win-win development with our partners.

Founded in 1989, SciClone Pharmaceuticals was listed on the NASDAQ stock exchange in the United States in 1992. In 2017, it was acquired by a consortium led by GL Capital and privatized from NASDAQ. SciClone Pharmaceuticals aspires to become a first-class pharmaceutical and healthcare company focused on the Chinese market. We sincerely invite elites from all fields to join SciClone and pursue mutual development!

Our Vision:
We focus on major and special disease treatment areas, striving to win patient trust, customer respect, and employee pride, achieving sustained growth, and becoming a first-class pharmaceutical and healthcare enterprise focused on the Chinese market.

Our Employer Value Proposition (EVP):
SciClone provides employees with a humanistic environment akin to international companies and a platform to showcase their talents, ensuring that employees' contributions are duly rewarded.

Our Values:
— Customer
Customer first: All our work centers on meeting the legitimate needs of our customers.
Our customers include both external and internal customers. External customers refer to patients and all stakeholders who serve patients, such as doctors, pharmacists, regulatory authorities, distributors, and partners. Internally, colleagues treat each other as customers.

— Win-Win
Starting from a win-win perspective, we treat both internal and external work partners with honesty, mutual trust, and mutual benefit in everything we do.

— Accountability
We demonstrate ownership, dare to make decisions, and bravely take responsibility. On the basis of completing our own work with quality and quantity, we proactively undertake additional important tasks and see them through to the end.

— Efficiency
Clear division of labor, streamlined processes; rapid response, effective execution; innovative problem-solving that balances effectiveness and efficiency.

— Performance
Results-oriented, with industry-average development levels as the starting point of our performance standards. We achieve high performance as the realization of self-worth, continuously climbing toward higher and more challenging performance goals, surpassing ourselves.

— Compliance
Compliance is the cornerstone of our business. We always adhere to the bottom line, follow rules, obey discipline, and do the right thing.